32 results
424B3
CDTX
Cidara Therapeutics, Inc.
2 Jan 25
Prospectus supplement
4:02pm
be impacted by broader macroeconomic conditions, including global pandemics, high inflation, bank failures, labor shortages, supply chain disruptions … based on its supply chain activities in 2023 and prior years. As of December 31, 2023, the Company recorded $18.0 million of accrued indirect tax
8-K
EX-10.1
lwhsf4g0p8kj
18 Jul 24
Departure of Directors or Certain Officers
4:31pm
8-K/A
EX-2.1
r7mbc8waqouh x6fvj9j
29 Apr 24
Entry into a Material Definitive Agreement
4:57pm
8-K
d45614o
16 Apr 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:02am
NT 10-K
7c8x5a4sacbu0k 4j
1 Apr 24
Notice of late annual filing
8:00am